SEC Form D · filed November 22, 2023
Alcyone Therapeutics, Inc
Industry
Other Health Care
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (21)
David Donabedian · Lowell, MADirectorSanjay Pal · Seattle, WAExec · DirectorTommi Unkuri · STOCKHOLM, V7DirectorCameron Durrant · Lowell, MADirectorEdgar D. Jannotta · Lowell, MADirectorHeath Wilson · Knoxville, TNDirectorPj Anand · Lowell, MAExec · DirectorNorbert D. Riedel · Lowell, MADirectorRichard Upton · Lowell, MADirectorEdgar D. Jannotta · Lowell, MADirectorLarry Page · Seattle, WADirectorJoseph Odom · Knoxville, TNDirectorStephen D. Oesterle · Lowell, MADirectorReynir G. Indahl · STOCKHOLM, V7DirectorStephen D. Oesterle · Lowell, MADirectorNorbert D. Riedel · Lowell, MADirectorChristian Melby · STOCKHOLM, V7DirectorPj Anand · Lowell, MAExec · DirectorDavid Donabedian · Lowell, MADirectorCameron Durrant · Lowell, MADirectorRichard Upton · Lowell, MADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗